Burkholderia cepacia genomovar III and Burkholderia vietnamiensis double infection in a cystic fibrosis child

J Cyst Fibros. 2002 Dec;1(4):292-4. doi: 10.1016/s1569-1993(02)00101-7.

Abstract

Herein we report a case of a cystic fibrosis child who was simultaneously infected with Burkholderia cepacia genomovar III and Burkholderia vietnamiensis. After antimicrobial therapy only B. cepacia genomovar III persisted.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amikacin / therapeutic use
  • Anti-Infective Agents / therapeutic use
  • Burkholderia / genetics
  • Burkholderia / isolation & purification*
  • Burkholderia Infections / complications*
  • Burkholderia Infections / drug therapy
  • Burkholderia Infections / microbiology*
  • Burkholderia cepacia complex / genetics
  • Burkholderia cepacia complex / isolation & purification
  • Ciprofloxacin / therapeutic use
  • Cystic Fibrosis / complications*
  • Cystic Fibrosis / microbiology*
  • Drug Resistance, Bacterial / genetics
  • Humans
  • Infant
  • Male
  • Respiratory Tract Infections / complications*
  • Respiratory Tract Infections / drug therapy
  • Respiratory Tract Infections / microbiology*
  • Treatment Outcome
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Infective Agents
  • Ciprofloxacin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Amikacin